Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00033788
DRKS00033788
Recruiting
Not Applicable

Biomarker Discovery in Exhaled Breath Condensate (EBC) to discriminate pts with lung cancer CS I-IV from pts with COPD or lung fibrosis and healthy controls. - Lung - EBC Biomarker Discovery

VOC-Advanced Breath Diagnostics GmbH0 sites238 target enrollmentMarch 4, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsC34.9Bronchus or lung, unspecified

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C34.9
Sponsor
VOC-Advanced Breath Diagnostics GmbH
Enrollment
238
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 4, 2024
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
VOC-Advanced Breath Diagnostics GmbH

Eligibility Criteria

Inclusion Criteria

  • •2\.Cohort classification:
  • •a. Cohort A: Smokers or nonsmokers with no signs or symptoms of lung cancer, COPD or lung fibrosis
  • •b.Cohort B: Smokers or nonsmokers with known COPD or lung fibrosis but no symptoms or signs of lung cancer
  • •c.Cohort C: Smokers or nonsmokers with yet untreated lung carcinoma CS I\-IV with or without COPD or lung fibrosis
  • •3\. Able to sign informed consent form.
  • •4\. Able to understand study requirements and to provide EBC sample by tidal breathing into a EBC collection device

Exclusion Criteria

  • •1\. Suffering from major uncontrolled medical conditions that may interfere with study requirements such as fever, shortness of breath, cough/acute cold.
  • •2\. Previous malignancies
  • •3\. Patients with COPD GOLD IV or lung fibrosis with DLCO/TCLO \< 30 %
  • •4\. Exacerbation of COPD within \= 4 weeks before enrollment
  • •5\. Dry mouth and tongue with daily liquid intake of \< 1 liter/day within last 48 hours

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Clinical investigation of biomarkers in exhaled breath with ion mobility spectrometry (IMS) and differential mobility spectrometry (DMS)C34.0J44E84.0J84Main bronchusOther chronic obstructive pulmonary diseaseCystic fibrosis with pulmonary manifestationsOther interstitial pulmonary diseases
DRKS00000314Kooperation der Abteilung für interventionelle Pneumologie (Chefarzt PD Lutz Freitag) und der Abteilung Pneumologie-Universitätsklinik (Chefarzt Prof. Helmut Teschler) des Westdeutsches Lungenzentrum am Universitätsklinikum90
Completed
Not Applicable
Inflammatory Markers in Exhaled Breath (Condensate) in Childhood AsthmaAsthmaHealthyChildren
NCT00404976Maastricht University Medical Center100
Completed
Not Applicable
Exhaled Breath Condensate Biomarkers of Inflammation in Individuals With Chronic Cervical Spinal Cord InjuryTetraplegiaAsthma
NCT02235714James J. Peters Veterans Affairs Medical Center36
Completed
Not Applicable
Biomarkers in exhaled breath condensate in asthma
JPRN-UMIN000015990Daisan hospital, Jikei university
Unknown
Phase 2
Usefulness of Exhaled Breath Condensate for Evaluation of Markers of Airway Inflammation in Children With AsthmaAsthma
NCT00961155Medical University of Lodz200